IN2014MU01100A - - Google Patents

Info

Publication number
IN2014MU01100A
IN2014MU01100A IN1100MU2014A IN2014MU01100A IN 2014MU01100 A IN2014MU01100 A IN 2014MU01100A IN 1100MU2014 A IN1100MU2014 A IN 1100MU2014A IN 2014MU01100 A IN2014MU01100 A IN 2014MU01100A
Authority
IN
India
Prior art keywords
present disclosure
salmonella
relates
colonization
delivery vehicle
Prior art date
Application number
Other languages
English (en)
Inventor
Sambuddha Ghosh
Sanjiban Kumar Banerjee
Manisha Pravin Sabnis
Original Assignee
Sambuddha Ghosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sambuddha Ghosh filed Critical Sambuddha Ghosh
Priority to BR112016022375-6A priority Critical patent/BR112016022375B1/pt
Priority to MX2016012597A priority patent/MX2016012597A/es
Priority to PCT/IB2015/000407 priority patent/WO2015145250A2/en
Priority to AU2015237933A priority patent/AU2015237933B2/en
Priority to EP15727063.8A priority patent/EP3122773B1/en
Priority to US15/129,661 priority patent/US10544208B2/en
Priority to CA2943903A priority patent/CA2943903C/en
Priority to CN201580027972.2A priority patent/CN107074934B/zh
Priority to IN1100MU2014 priority patent/IN2014MU01100A/en
Publication of IN2014MU01100A publication Critical patent/IN2014MU01100A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN1100MU2014 2014-03-27 2015-03-27 IN2014MU01100A (tr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BR112016022375-6A BR112016022375B1 (pt) 2014-03-27 2015-03-27 Expressão de um anticorpo de cadeia única contra salmonella em lactobacillus
MX2016012597A MX2016012597A (es) 2014-03-27 2015-03-27 Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus.
PCT/IB2015/000407 WO2015145250A2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
AU2015237933A AU2015237933B2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against Salmonella in Lactobacillus
EP15727063.8A EP3122773B1 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
US15/129,661 US10544208B2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against Salmonella in Lactobacillus
CA2943903A CA2943903C (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
CN201580027972.2A CN107074934B (zh) 2014-03-27 2015-03-27 在乳杆菌中表达针对沙门氏菌的单链抗体
IN1100MU2014 IN2014MU01100A (tr) 2014-03-27 2015-03-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1100MU2014 IN2014MU01100A (tr) 2014-03-27 2015-03-27

Publications (1)

Publication Number Publication Date
IN2014MU01100A true IN2014MU01100A (tr) 2015-10-02

Family

ID=54196512

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1100MU2014 IN2014MU01100A (tr) 2014-03-27 2015-03-27

Country Status (8)

Country Link
US (1) US10544208B2 (tr)
EP (1) EP3122773B1 (tr)
CN (1) CN107074934B (tr)
AU (1) AU2015237933B2 (tr)
CA (1) CA2943903C (tr)
IN (1) IN2014MU01100A (tr)
MX (1) MX2016012597A (tr)
WO (1) WO2015145250A2 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016012597A (es) 2014-03-27 2017-04-27 Sambuddha Ghosh Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus.
AU2016214059B2 (en) * 2015-02-04 2021-08-05 Abcelex Technologies Inc. Anti-salmonella antibodies and uses thereof
WO2017199094A1 (en) * 2016-05-20 2017-11-23 Novobind Livestock Therapeutics Inc. Antibodies against microorganisms and uses thereof
US20220119506A1 (en) * 2018-06-05 2022-04-21 Novobind Livestock Therapeutics Inc. Antibodies against aquaculture disease-causing agents and uses thereof
CN108864281B (zh) * 2018-07-13 2020-09-08 西北农林科技大学 一种抗肠炎沙门氏菌的纳米抗体及其应用
CN113564095B (zh) * 2021-07-27 2023-10-20 陈玉松 外源核苷酸在促进干酪乳杆菌拮抗肠沙门氏菌方面的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1499191B1 (en) * 2002-04-15 2012-05-09 Washington University in St. Louis Regulated attenuation of live vaccines to enhance cross protective immunogenicity
US8105592B2 (en) 2004-11-25 2012-01-31 Vhsquared Limited Heavy chain and single domain antibodies
BRPI0615547A2 (pt) 2005-08-19 2011-05-24 Unilever Nv produto alimentìcio, preparação farmacêutica, método de fabricação de produto alimentìcio, método de fabricação de preparação farmacêutica, uso do produto alimentìcio, usos da preparação farmacêutica, método de fornecimento de benefìcios à saúde do intestino e implementos de liberação para uso com produto alimentìcio
CN101469333B (zh) * 2007-12-25 2014-01-22 温州医学院 一种抗沙门菌单链抗体与跨膜蛋白融合蛋白的制备方法
GB0816462D0 (en) * 2008-09-09 2008-10-15 Univ Birmingham Non-typoidal salmonella vaccines
MX2016012597A (es) 2014-03-27 2017-04-27 Sambuddha Ghosh Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus.

Also Published As

Publication number Publication date
US20170152305A1 (en) 2017-06-01
CN107074934B (zh) 2021-06-29
WO2015145250A3 (en) 2016-01-21
CA2943903A1 (en) 2015-10-01
US10544208B2 (en) 2020-01-28
AU2015237933B2 (en) 2020-09-17
EP3122773B1 (en) 2020-07-22
MX2016012597A (es) 2017-04-27
CA2943903C (en) 2023-03-14
CN107074934A (zh) 2017-08-18
BR112016022375A2 (pt) 2019-01-15
AU2015237933A1 (en) 2016-10-20
EP3122773A2 (en) 2017-02-01
WO2015145250A2 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
PH12016501763A1 (en) Multispecific antibodies
IN2014MU01100A (tr)
MX2017007941A (es) Anticuerpos antagonistas anti-axl.
MX2016016881A (es) Anticuerpos que se unen a axl.
PL2937424T3 (pl) Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
EP3604535A3 (en) Methods and compositions for weed control
MX2016014862A (es) Her3 / her2 anticuerpos biespecificos que se unen a la horquilla beta de her3 y al dominio ii de her2.
MX2016016886A (es) Anticuerpos anti-axl.
EP3132022A4 (en) Synthetic methanotrophic and methylotrophic microorganisms
ZA201608394B (en) Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
MY179341A (en) Method for producing l-amino acids using an alkaliphilic bacteria
HUE044330T2 (hu) Lactobacillus salivarius, emlõmirigy-gyulladás kezelésére
EP3158065A4 (en) Nucleic acids and vectors for use with methanotrophic bacteria
EP3270741A4 (en) SMART PILLOW
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
MX2015017638A (es) Polioles que contienen tanino, su producción y su uso.
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
MX2015014121A (es) Producto alimenticio y/o ingrediente alimenticio.
MX2019006090A (es) Metodos para mejorar la respuesta inmune con everolimus, dactolisib o ambos.
MX2016014416A (es) Anticuerpos anti-her3 que se unen a la horquilla beta de her3.
MY184391A (en) Microorganism having improved intracellular energy level and method for producing l-amino acid using same
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
EP3165599A4 (en) Novel lactic acid bacterium and composition including said lactic acid bacterium
PT3049102T (pt) Lactoferrina para o tratamento de ibd associadas a invasão bacteriana
PL3153575T3 (pl) Mikroorganizm mający zdolność wytwarzania o-sukcynylohomoseryny lub kwasu bursztynowego oraz sposób wytwarzania kwasu bursztynowego lub o-sukcynylohomoseryny z jego użyciem